Cargando…
Pharmacokinetics and safety of oral glyburide in dogs with acute spinal cord injury
BACKGROUND: Glyburide (also known as glibenclamide) is effective in reducing the severity of tissue destruction and improving functional outcome after experimental spinal cord injury in rodents and so has promise as a therapy in humans. There are many important differences between spinal cord injury...
Autores principales: | Jeffery, Nick, Boudreau, C. Elizabeth, Konarik, Megan, Mays, Travis, Fajt, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831157/ https://www.ncbi.nlm.nih.gov/pubmed/29503767 http://dx.doi.org/10.7717/peerj.4387 |
Ejemplares similares
-
SCING—Spinal Cord Injury Neuroprotection with Glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA
por: Minnema, Amy Janelle, et al.
Publicado: (2019) -
Ambulation in Dogs With Absent Pain Perception After Acute Thoracolumbar Spinal Cord Injury
por: Lewis, Melissa J., et al.
Publicado: (2020) -
Quantification of spinal ataxia in dogs with thoracolumbar spinal cord injury
por: Sherif, Tamara, et al.
Publicado: (2023) -
Clinical Features of Spinal Cord Hemangioblastoma in a Dog
por: Michaels, Jennifer, et al.
Publicado: (2015) -
Bladder and Bowel Management in Dogs With Spinal Cord Injury
por: Granger, Nicolas, et al.
Publicado: (2020)